|
|
||||||||
1 Department of Medicine, The Christchurch School of Medicine, Christchurch, New Zealand; 2 Schering-Plough Research Institute, Kenilworth, New Jersey 07033-0539; and 3 Scios, Mountain View, California 94043
The effects of separate and combined
endopeptidase inhibition (by SCH-32615) and natriuretic peptide
receptor C blockade [by C-ANP-(4
23)] on the clearance and
bioactivity of atrial (ANP) and brain (BNP) natriuretic peptides was
investigated in eight sheep with heart failure. SCH-32615 and
C-ANP-(4
23) administered separately induced significant and
proportionate dose-dependent rises in plasma ANP, BNP, and guanosine
3',5'-cyclic monophosphate (cGMP) levels. Associated with
these changes were reductions in arterial pressure, left atrial
pressure, and peripheral resistance and increases in cardiac output,
urine volume, sodium excretion, and creatinine clearance. SCH-32615
induced greater diuresis and natriuresis than C-ANP-(4
23). Combined
administration of SCH-32615 and C-ANP-(4
23) induced greater than
additive rises in plasma ANP, BNP, and cGMP concentrations, with
enhanced hemodynamic effects, diuresis, and natriuresis and reduced
plasma aldosterone levels. In conclusion, we find that the enzymatic
and receptor clearance pathways contribute equally to the metabolism of
endogenous ANP and BNP in sheep with heart failure. Combined inhibition
of both degradative pathways was associated with enhanced hormonal,
hemodynamic, and renal effects and may have greater potential
therapeutic value than either agent separately.
guanosine 3',5'-cyclic monophosphate; ventricular pacing; hemodynamics; natriuresis
This article has been cited by other articles:
![]() |
T. E. H. Christoffersen, M. Aplin, C. C. Strom, S. P. Sheikh, O. Skott, P. K. Busk, S. Haunso, and L. B. Nielsen Increased natriuretic peptide receptor A and C gene expression in rats with pressure-overload cardiac hypertrophy Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1635 - H1641. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schou, M. K. Dalsgaard, O. Clemmesen, E. A. Dawson, C. C. Yoshiga, H. B. Nielsen, F. Gustafsson, P. R. Hildebrandt, and N. H. Secher Kidneys extract BNP and NT-proBNP in healthy young men J Appl Physiol, November 1, 2005; 99(5): 1676 - 1680. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Almirez and A. A. Protter Clearance of Human Brain Natriuretic Peptide in Rabbits; Effect of the Kidney, the Natriuretic Peptide Clearance Receptor, and Peptidase Activity J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 976 - 980. [Abstract] [Full Text] |
||||
![]() |
C. J. Pemberton, T. G. Yandle, M. T. Rademaker, C. J. Charles, G. D. Aitken, and E. A. Espiner Amino-terminal proBNP in ovine plasma: evidence for enhanced secretion in response to cardiac overload Am J Physiol Heart Circ Physiol, October 1, 1998; 275(4): H1200 - H1208. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |